Ventas (NYSE:VTR) Issues FY 2026 Earnings Guidance
by Renee Jackson · The Cerbat GemVentas (NYSE:VTR – Get Free Report) updated its FY 2026 earnings guidance on Monday. The company provided EPS guidance of 3.820-3.890 for the period, compared to the consensus EPS estimate of 3.850. The company issued revenue guidance of -.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on VTR. Cantor Fitzgerald reiterated an “overweight” rating and set a $93.00 price target on shares of Ventas in a research report on Monday, February 9th. Morgan Stanley set a $90.00 price target on Ventas in a research report on Friday, February 13th. KeyCorp increased their price target on Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Mizuho increased their price target on Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 4th. Finally, Argus set a $88.00 price target on Ventas in a research report on Tuesday, February 10th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Ventas presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.47.
Check Out Our Latest Report on Ventas
Ventas Stock Performance
VTR stock traded up $1.15 on Monday, reaching $84.77. The company’s stock had a trading volume of 5,892,468 shares, compared to its average volume of 3,173,119. Ventas has a 52 week low of $61.76 and a 52 week high of $88.36. The company has a market capitalization of $40.30 billion, a P/E ratio of 156.98, a price-to-earnings-growth ratio of 2.06 and a beta of 0.75. The firm has a fifty day moving average of $84.70 and a two-hundred day moving average of $79.66. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67.
Ventas (NYSE:VTR – Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. During the same period last year, the company earned $0.81 earnings per share. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, analysts predict that Ventas will post 3.85 EPS for the current fiscal year.
Ventas Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 16th. Investors of record on Tuesday, March 31st were issued a $0.52 dividend. This is a positive change from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s dividend payout ratio is currently 385.19%.
Insider Buying and Selling
In related news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This represents a 0.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president directly owned 72,755 shares of the company’s stock, valued at $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.53% of the company’s stock.
Hedge Funds Weigh In On Ventas
A number of institutional investors and hedge funds have recently added to or reduced their stakes in VTR. Wiser Advisor Group LLC bought a new position in Ventas during the 3rd quarter valued at $27,000. IFC & Insurance Marketing Inc. bought a new position in Ventas during the 4th quarter valued at $30,000. Zions Bancorporation National Association UT boosted its stake in Ventas by 250.3% during the 4th quarter. Zions Bancorporation National Association UT now owns 508 shares of the real estate investment trust’s stock valued at $39,000 after purchasing an additional 363 shares in the last quarter. DV Equities LLC bought a new position in Ventas during the 4th quarter valued at $51,000. Finally, Rossby Financial LCC boosted its stake in Ventas by 45.8% during the 4th quarter. Rossby Financial LCC now owns 729 shares of the real estate investment trust’s stock valued at $56,000 after purchasing an additional 229 shares in the last quarter. 94.18% of the stock is owned by institutional investors.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.